
Nektar Therapeutics (NKTR) Earnings Dates & Reports
Nektar Therapeutics (NKTR) Most Recent Earnings
Report Date
Period EndingQ1 2026
Est. EPS-$1.53
Actual EPS-$1.82
EarningsMiss
Nektar Therapeutics (NKTR) Earnings
View the latest Nektar Therapeutics (NKTR) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Nektar Therapeutics (NKTR)
Order type
Buy in
Order amount
Est. shares
0 shares
Nektar Therapeutics (NKTR) Earnings per Share (EPS) History
Signup for full accessBrowse free
Nektar Therapeutics (NKTR) Latest Earnings
The value each NKTR share was expected to gain vs. the value each share gained.
Nektar Therapeutics (NKTR) reported its most recent earnings on for Q1 2026, posting earnings per share (EPS) of -$1.82. This exceeded analysts' expectations of -$1.53 by 18.95%, marking a Miss.
For comparison, Nektar Therapeutics reported EPS of -$3.60 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$2.05.
Nektar Therapeutics (NKTR) Earnings History
Nektar Therapeutics (NKTR) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Nektar Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
Nektar Therapeutics (NKTR) Earnings FAQs
Nektar Therapeutics (NKTR) last reported earnings on May 7, 2026 for Q1 2026, posting an EPS of -$1.82, which Miss the estimate of -$1.53 by 18.95%.
For Q1 2026, Nektar Therapeutics (NKTR) reported an EPS of -$1.82, missing analysts' estimate of -$1.53 by 18.95%.
For Q1 2026, Nektar Therapeutics (NKTR) Miss expectations with an actual EPS of -$1.82 vs. an estimated EPS of -$1.53.
Following the last earnings report on May 7, 2026, Nektar Therapeutics (NKTR)'s stock price moved — from — to —.
The next Nektar Therapeutics (NKTR) earnings call is scheduled for Aug. 6, 2026, where executives will discuss financial results and outlook.